Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 0.36 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.33 |
| ▸ | MEN1 | O00255 | 6/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18962110 | 0.98 | MAPT (0.35) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18962065 | 0.96 | TSHR (0.37) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18962143 | 0.95 | MAPT (0.34) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18961970 | 0.94 | MAPT (0.34) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18961942 | 0.94 | TSHR (0.36) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18962112 | 0.93 | MAPT (0.31) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18962066 | 0.92 | TSHR (0.36) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL19679647 | 0.91 | TSHR (0.31) | MAPTTSHRKMT2AMEN1CSF1R | |
| SCHEMBL18962154 | 0.91 | TSHR (0.35) | MAPTTSHRNPSR1ALDH1A1LMNA | |
| SCHEMBL18961940 | 0.91 | MAPT (0.30) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10873034-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-12-22 | — | — | US | disclosed |
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-03 | — | — | US | disclosed |
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-03 | — | — | US | disclosed |
| US-20170237015-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
| US-20170237015-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-08-17 | — | — | US | disclosed |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237015-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNA1, ARL1 | MAPT 1277/4885TSHR 3601/4885NPSR1 3677/4885 |
| US-10011608-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | PIEZO1, OR51E2, OCIAD1 | MAPT 2471/4885TSHR 4640/4885NPSR1 4679/4885 |
| US-10873034-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNA1, ARL1 | MAPT 1277/4885TSHR 3601/4885NPSR1 3677/4885 |
| US-20170166581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OCIAD1 | MAPT 2471/4885TSHR 4640/4885NPSR1 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.